• Citer

A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

par Karampeazis, A;Vamvakas, L.;Agelaki, Sofia;Kentepozidis, N;Papadimitraki, E;Gioulbasanis, I.;Vardakis, N;Ignatiadis, Michail ;Mavroudis, Dimitris;Georgoulias, Vassilis
Référence Oncology, 71, 5-6, page (347-353)
Publication Publié, 2006

Article révisé par les pairs

• Détails
• Contenu

Titre:	A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
Auteur:	Karampeazis, A; Vamvakas, L.; Agelaki, Sofia; Kentepozidis, N; Papadimitraki, E; Gioulbasanis, I.; Vardakis, N; Ignatiadis, Michail; Mavroudis, Dimitris; Georgoulias, Vassilis
Informations sur la publication:	Oncology, 71, 5-6, page (347-353)
Statut de publication:	Publié, 2006
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Administration, Oral
	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
	Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives
	Dose-Response Relationship, Drug
	Drug Administration Schedule
	Female
	Humans
	Male
	Maximum Tolerated Dose
	Middle Aged
	Nausea -- chemically induced
	Neoplasms -- drug therapy
	Neutropenia -- chemically induced
	Treatment Outcome
	Vinblastine -- administration & dosage -- adverse effects -- analogs & derivatives
Langue:	Anglais
Identificateurs:	urn:issn:0030-2414
	info:doi/10.1159/000107794
	info:pii/000107794
	info:pmid/17785992